跳至主要内容
临床试验/JPRN-UMIN000005363
JPRN-UMIN000005363招募中1 期

Clinical dose-finding and pharmacokinetic study of gemcitabine in patients with biliary tract or pancreatic cancer with liver dysfunction - Clinical dose-finding and pharmacokinetic study of gemcitabine in patients with biliary tract or pancreatic cancer with liver dysfunction

agoya university hospital0 个研究点目标入组 30 人开始时间: 2011年4月1日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients have received in the past gemcitabine hydrochloride monotherapy 2) Total bilirubin >10x ULN 3) Serum creatinin >1.5x ULN 4) Performance status 2 in classification of severe liver dysfunction 5) patients with interstitial pneumonia or pulmonary fibrosis on chest X-ray and having clinical symptoms 6) Patients with infections requiring treatment 7) Patients with uncontrolled diabetes despite the enforcement of appropriate drug therapy (including insulin) 8) it is clear that patients with constitutional jaundice 9) HBc antibody, HCV antibody, HIV antibody or syphilis positive 10) In addition, patients were judged inappropriate to participate in the clinical trial

研究者

发起方
agoya university hospital

相似试验

Clinical dose-finding and pharmacokinetic study of... | 临床试验